Back to search results
NCT07544576

Comparing Treatment of Knee Osteoarthritis With Triamcinolone Injections Using 40mg With Landmark Guidance and 20mg With Ultrasound Guidance

Enrolling by Invitation
PHASE4Ages 50+InterventionalTreatment
Sosi Dzhugarian
~140 participants
Updated 2026-04-22 on ClinicalTrials.gov
What's tested:Triamcinolone knee injection without ultrasound guidanceTriamcinolone knee injection with ultrasound guidance

At a glance

Recruiting sites
0 of 4 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Western Ontario and McMaster Universities Index
Measured over From enrollment to 3 months
+1 more outcome measured

Conditions

Knee Arthritis Osteoarthritis

Explore related trials

Osteoarthritis of knee

Where it's being run

4 sites across 1 states
California4

Study leadership

  • Griffin Elbert, DO · PRINCIPAL_INVESTIGATOR · Community Memorial Healthcare

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Subjects who have already been evaluated within at least one of the 4 study clinics with any of the 3 providers who will be administering the treatment
Males or females age 50 and older
Already had completion of imaging of the affected knee(s) via radiography and/or MRI
Imaging demonstrates osteoarthritis of any severity
Diagnosis of primary osteoarthritis of one or both knees
One or more symptoms associated with the osteoarthritis of at least one knee
Patients able to provide informed consent in English and/or Spanish

Exclusion

Skin infection at or near area of injection site
Recent fracture of the same knee joint within past 6 months
Uncontrolled bleeding disorder
Intra-articular corticosteroid injection within past 3 months
Intra-articular HA injection within the past 3 months
Intra-articular PRP injection within the past 3 months
Presence of prosthetic knee joint in symptomatic knee
Inability to report symptoms due to cognitive impairment
Complete inability to ambulate, even with assistive device
Any person who is pregnant or less than 1 year post-menopause

What this trial measures

  • Western Ontario and McMaster Universities IndexFrom enrollment to 3 months

    Scores are on a scale of 0 through 96, with a higher score indicating a worse function level.

  • Pain Visual Analog ScaleFrom enrollment to 3 months

    scale of 0 through 10, with 10 being the highest pain level.